MeiraGTx Holdings plc (MGTX)
NASDAQ: MGTX · Real-Time Price · USD
7.38
+0.38 (5.43%)
Mar 9, 2026, 3:33 PM EDT - Market open
MeiraGTx Holdings Employees
MeiraGTx Holdings had 381 employees as of December 31, 2024. The number of employees decreased by 44 or -10.35% compared to the previous year.
Employees
381
Change (1Y)
-44
Growth (1Y)
-10.35%
Revenue / Employee
$67,034
Profits / Employee
-$412,440
Market Cap
594.02M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Rigel Pharmaceuticals | 164 |
| Alpha Tau Medical | 125 |
| Solid Biosciences | 100 |
| Ocugen | 95 |
| enGene Holdings | 82 |
| Verastem | 78 |
| Larimar Therapeutics | 65 |
| Design Therapeutics | 55 |
MGTX News
- 4 weeks ago - ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy - PRNewsWire
- 3 months ago - Graviton Bioscience to Present Selective ROCK2 Obesity Data at 8th Annual Evercore HealthCONx Conference - PRNewsWire
- 4 months ago - MeiraGTx Reports Third Quarter 2025 Financial and Operational Results - GlobeNewsWire
- 4 months ago - Eli Lilly signs deal for MeiraGTx's gene therapy for severe eye disease - Reuters
- 4 months ago - MeiraGTx Enters into Strategic Collaboration with Eli Lilly and Company to Develop and Commercialize Genetic Medicines in Ophthalmology - GlobeNewsWire
- 5 months ago - MeiraGTx Announces Two Posters at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress - GlobeNewsWire
- 7 months ago - MeiraGTx Reports Second Quarter 2025 Financial and Operational Results - GlobeNewsWire
- 10 months ago - MeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting - GlobeNewsWire